Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.950
-0.130 (-2.56%)
Apr 30, 2026, 10:51 AM EDT - Market open
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $11.35 million as of April 30, 2026. Its market cap has increased by 458.59% in one year.
Market Cap
11.35M
Enterprise Value
4.50M
1-Year Change
458.59%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $11.35M, a decrease of -96.49%. That is a compound annual growth rate of -53.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 11.65M | 726.01% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 14.69M |
| Hoth Therapeutics | 14.15M |
| Phio Pharmaceuticals | 13.94M |
| Moleculin Biotech | 13.61M |
| Citius Pharmaceuticals | 13.44M |
| Traws Pharma | 13.31M |
| Jupiter Neurosciences | 13.06M |
| Intensity Therapeutics | 12.88M |